We found that praja2 was expressed at higher levels in IDH1 wild-type astrocytoma, oligoastrocytoma, and glioblastoma, compared to the counterpart glioma lesions carrying mutant IDH1 (Supplementary Fig. 1a). This evidence concerns the gene PJA2 and central nervous system cancer.